Bemidji Chamber Ambassadors welcomed Clinical Director and Occupational Therapist Kayla Borszich of Little Miracles, Inc. on her new Bemidji clinic, located at 1710 Paul Bunyan Drive NW, Bay 111.

A recent study published in the Journal of the American Dental Association found that Tirzepatide presented a novel strategy ...

Panelists discuss how intrathecal delivery of onasemnogene abeparvovec in the STEER study demonstrates statistically significant motor function improvements in older patients with SMA (ages 2-18 years ...

Scientists discover that dental pulp stem cells from wisdom teeth could regenerate neurons and bones and offer treatments for ...

MIRA is advancing complementary non-opioid therapies for two of the largest pain markets MIAMI, FLORIDA / ACCESS Newswire / ...

R09b, for the treatment of Primary Parkinson’s Disease (PD), has received Fast Track Designation (FTD) from the U.S. Food and ...

It will grow to $9.02 billion in 2029 at a compound annual growth rate (CAGR) of 15.3%.” — The Business Research Company LONDON, GREATER LONDON, UNITED KINGDOM, July 3, 2025 /EINPresswire.com/ -- Save ...

Neurizon Therapeutics has inked an exclusive global licensing deal with New York Stock Exchange-listed Elanco Animal Health ...

UCB announces phase 3 study of fenfluramine in CDKL5 deficiency disorder meets primary and key secondary endpoints: Brussels, Belgium Monday, June 30, 2025, 11:00 Hrs [IST] UCB, a ...

UCB announces positive results from GEMZ phase 3 study of fenfluramine in CDKL5 Deficiency DisorderPhase 3 study met primary and key secondary clinical endpoints, marking the third developmental and ...

In addition, this data showed that crofelemer reduced stool volume output and/or frequency of watery stools, and increased urine output – an indicator of improved nutrient oral absorption ... the ...

Castor oil is enjoying a recent surge in popularity. But is it really good for you and safe to consume? Registered ...